Catherine Stehman-breen - Net Worth and Insider Trading

Catherine Stehman-breen Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Catherine Stehman-breen owns 4 companies in total, including Dyne Therapeutics Inc (DYN) , Generation Bio Co (GBIO) , and Sarepta Therapeutics Inc (SRPT) among others .

Click here to see the complete history of Catherine Stehman-breen’s form 4 insider trades.

Insider Ownership Summary of Catherine Stehman-breen

Ticker Comapny Transaction Date Type of Owner
DYN Dyne Therapeutics Inc 2020-09-16 director
GBIO Generation Bio Co 2020-06-11 director
SRPT Sarepta Therapeutics Inc 2017-04-03 SVP & Chief Medical Officer
LIMIT LIMIT 2021-07-29 director

Catherine Stehman-breen Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Catherine Stehman-breen Ownership Network

Ownership Network List of Catherine Stehman-breen

No Data

Ownership Network Relation of Catherine Stehman-breen

Insider Network Chart

Catherine Stehman-breen Owned Company Details

What does Dyne Therapeutics Inc do?

Who are the key executives at Dyne Therapeutics Inc?

Catherine Stehman-breen is the director of Dyne Therapeutics Inc. Other key executives at Dyne Therapeutics Inc include director & 10 percent owner Dirk Kersten , See Remarks Richard William Scalzo , and Chief Operating Officer Susanna Gatti High .

Dyne Therapeutics Inc (DYN) Insider Trades Summary

Over the past 18 months, Catherine Stehman-breen made no insider transaction in Dyne Therapeutics Inc (DYN). Other recent insider transactions involving Dyne Therapeutics Inc (DYN) include a net sale of 446,445 shares made by Dirk Kersten , a net sale of 327,516 shares made by Richard William Scalzo , and a net sale of 273,683 shares made by Susanna Gatti High .

In summary, during the past 3 months, insiders sold 1,954,064 shares of Dyne Therapeutics Inc (DYN) in total and bought 32,000 shares, with a net sale of 1,922,064 shares. During the past 18 months, 7,985,414 shares of Dyne Therapeutics Inc (DYN) were sold and 1,746,285 shares were bought by its insiders, resulting in a net sale of 6,239,129 shares.

Dyne Therapeutics Inc (DYN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Dyne Therapeutics Inc Insider Transactions

No Available Data

Catherine Stehman-breen Mailing Address

Above is the net worth, insider trading, and ownership report for Catherine Stehman-breen. You might contact Catherine Stehman-breen via mailing address: 215 First Street, Suite 415, Cambridge Ma 02142.